Chinese pharmaceutical enterprises are moving from exporting single products to engaging in systematic and ecological collaborations as part of their global strategy, executives from the United States ...

The merger expands the combined entity’s manufacturing, research, and development capabilities, with a focus on specialty ...

Portfolio Receipts growth of 10% to $925 million; Royalty Receipts growth of 13%Net cash provided by operating activities of $718 millionRaised ...

Having spent 12 years on Capitol Hill, I know just how rare it is to find an issue with real bipartisan consensus. That’s why ...

Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, integrated biopharmaceutical company engaged in ...

Latitude Investment Management, an investment management firm, released its fourth-quarter 2025 investor letter. A copy of ...

Detailed price information for Ascentage Pharma Group Intl ADR (AAPG-Q) from The Globe and Mail including charting and trades.

CSL has slashed its revenue projection for the fiscal year from $15.8 billion to $15.2 billion, in another indication of the ...

The U.S. Department of Commerce's Bureau of Industry and Security (BIS) has issued procedures for pharmaceutical manufacturers to apply ...

The agency’s top food official will step in to the role after Dr. Makary privately said he opposed the administration ...

PRIME Minister, Brigadier (Ret’d) Mark Phillips has hailed the expanding cooperation between Guyana and the European Union in ...